Stephen M. Pastores, MD, FACP, FCCP, FCCM

Internist, Pulmonologist & Intensivist

Director, Critical Care Medicine Fellowship Program; Director, Critical Care Research

Pictured: Stephen Pastores

About Me

I joined the Memorial Sloan Kettering staff in 1999 and have served as the director of the critical care medicine fellowship and research programs in the Department of Anesthesiology and Critical Care Medicine since 2003. As fellowship director, I am in charge of the day-to-day operation of the program, including the development and implementation of the educational curriculum for our fellows and in discussing their evaluations, research projects, and career options. I am also a Professor of Medicine in Anesthesiology and Medicine at Weill Cornell Medical College. I serve as principal investigator for several clinical trials in septic shock and acute lung injury. In addition to my clinical and research activities at Memorial Sloan Kettering, I am actively involved in critical care medicine at a national level serving as a member of the Board of Regents of the Society of Critical Care Medicine and a member of the editorial boards of CHEST and Journal of Critical Care. In 2013, I was the recipient of the Distinguished Service Award from the Society of Critical Care Medicine for exceptional leadership contributions to the vision and mission of the Society. 

Read more
  • Clinical Expertise: Critical Care Medicine
  • Languages Spoken: English
  • Education: MD, Lyceum-Northwestern College (Philippines)
  • Residencies: Metropolitan Hospital Center/New York Medical College
  • Fellowships: New York University Medical Center; Mount Sinai Medical Center (New York)
  • Board Certifications: Internal Medicine; Pulmonary Disease; Critical Care Medicine

New Patient Appointments

Making an appointment

Call 800-525-2225

See My Colleagues

Publications

Mokart D, Pastores SM, Darmon M. Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 2014;40:1570-2. [pmid:25160033]

Fessler HE, Addrizzo-Harris D, Beck JM, Buckley JD, Pastores SM, Piquette CA, Rowley JA, Spevetz A. Entrustable Professional Activities and Curricular Milestones for Fellowship Training in Pulmonary and Critical Care Medicine: Report of a multi-society working group. Chest 2014;146(3):813-34. [pmid:24945874]

Read more

Joffe AM, Pastores SM, Maerz LL, Mathur P, Lisco SJ. Utilization and impact on fellowship training of non-physician advanced practice providers in intensive care units of academic medical centers: a survey of critical care program directors. J Crit Care. 2014 Feb;29(1):112-5. [pmid:24268625]

Pastores SM, Martin GS, Baumann MH, et al. Training internists to meet critical care needs in the United States: a consensus statement from the Critical Care Societies Collaborative (CCSC). CCSC Task Force on Critical Care Educational Pathways in Internal Medicine. Crit Care Med. 2014 May;42(5):1272-9. [pmid:24637881]

Pastores SM, DeSancho MT. Dalteparin was at least as effective as UFH for VTE prevention in critically ill patients with similar costs. ACP Journal Club 2015;162(6):JC13. [pmid:25775344]

Cheng B, Hoeft AH, Book M, Shu Q, Pastores SM. Sepsis: pathogenesis, biomarkers, and treatment. Biomed Res Int. 2015;2015:846935. [pmid:25834828]

Pastores SM, Kvetan V. Shortage of intensive care specialists in the United States: recent insights and proposed solutions. Rev Bras Ter Intensiva. 2015 Jan-Mar;27(1):5-6. [pmid:25909306]

Kamat S, Chawla S, Rajendram P, Pastores SM, Kostelecky N, Halpern NA. An analysis of patients transferred to a tertiary oncological intensive care unit for defined procedures. Am J Crit Care. 2015 May;24(3):241-7. [pmid:25934721]

Pastores SM, Halpern NA. Insights into ICU bed expansion in the US: national and regional analysis. Am J Respir Crit Care Med 2015;191(4):365-6.

Pastores SM, Halpern NA, Oropello JM, Kvetan V. Intensivist Workforce in the US: The Crisis is Real, Not Imagined. Am J Respir Crit Care Med 2015;191(6):718-9. [pmid:25767929]

Pastores SM, Voigt LP. Acute respiratory failure in the patient with cancer: diagnostic and management strategies.. Critical Care Clinics 2010; 26 :21-40

Kirkland LL, Parham WM, Pastores SM. Approaching hospital administrators about adopting cooling technologies. Critical Care Medicine 2009; 37 :S290-4

Halpern NA, Pastores SM. Critical Care Medicine in the USA 2000-2005: an analysis of bed numbers, use, and costs. Critical Care Medicine 2009;

Pastores SM. Management of Pulmonary Embolism in the Intensive Care Unit. Journal of Critical Care 2009; 24 :185-91

Marik PE, Pastores SM, Kavanagh BP. Corticosteroids for septic shock. New England Journal of Medicine 2009; 358 :2069-70

Marik P, Myburgh J, Annane D, Vincent JL, Pastores S, Meduri GU, Beishuizen A. What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit?. Annals of Internal Medicine 2008; 149 :770-1

Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, et al.. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Critical Care Medicine 2008; 36 :1937-49

Halpern NA, Pastores SM, Thaler HT, Greenstein RJ. Critical care medicine use and cost among Medicare beneficiaries 1995-2000: major discrepancies between two U.S. federal Medicare databases. Critical Care Medicine 2007; 35 :692-9

Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA. Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Critical Care 2007; 11 :R48

Pastores SM, Shaw A, Williams MD, Mongan E, Alicea M, Halpern NA. A Safety Evaluation of Drotrecogin alfa (activated) in Hematopoietic Stem Cell Transplant Patients with Severe Sepsis: Lessons in Clinical Research. Bone Marrow Transplantation 2005;36:721-24.

Pastores SM, Papadopoulos E, van den Brink M, Alicea M, Halpern N: Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C. Bone Marrow Transplantation 2002;30:131-134.

Pastores SM. Technological Innovations in organ support for hepatic, renal and hematologic failure. NVIC (Netherlands Journal of Intensive Care) 2001;5:46-49.

Abraham E, Laterre PF, Garbino J, Pingleton S, Butler T, Dugernier T, Margolis B, Kudsk K, et al, Halpern N, Pastores SM et al of the Tenefuse Study Group. Crit Care Med 2001;29:503-510.

Pastores SM: Acute Respiratory Failure: Diagnosis and Management. Oncology and Critical Care. Critical Care Clinics of North America, Vol 17(3), July 2001, pp. 623-646.

Halpern NA, Pastores SM, Oropello JM (editors). ICU Bedside Technology. Critical Care Clinics of North America. Philadelphia: W.B. Saunders Company, 2000:545.

Maguire PJ, Stevens C, Humes HD, Shander A, Halpern NA, Pastores SM. Bioartificial Organ Support for Hepatic, Renal and Hematologic Failure. In Halpern NA, Pastores SM, Oropello JM, Eds, ICU Bedside Technology: A Look into the 21st Century, Critical Care Clinics of North America, Vol 16(4), October 2000, pp 681-694.

Pastores SM, Halpern NA. Acquisition Strategies for Critical Care Technology. In: Halpern NA, Pastores SM, Oropello JM, Eds, ICU Bedside Technology: A Look into the 21st Century, Critical Care Clinics of North America, Vol 16(4), October 2000, pp 545-556.

Pastores SM, Halpern N. Striving to get new technology into the critical care environment. Journal of Critical Illness 2000;15(7):351-357.

Halpern NA, Pastores SM, Baker-Price J, Alicea M. The many causes of acute hearing loss in the ICU. Clinical Update. J Crit Illness 1999;14:398-402.

 


Visit PubMed for a full listing of Stephen M. Pastores’ journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more